Alain Schaffter
Director of Finance/CFO at BACHEM HOLDING AG
Net worth: 62 352 $ as of 2024-03-30
Profile
Mr. Alain Schaffter is a Chief Financial Officer at Bachem Holding AG and a Chief Financial Officer at Solvias AG.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2022-12-30 | 650 ( 0.00% ) | 62 352 $ | 2024-03-30 |
Alain Schaffter active positions
| Companies | Position | Start |
|---|---|---|
| BACHEM HOLDING AG | Director of Finance/CFO | 2021-01-31 |
Former positions of Alain Schaffter
| Companies | Position | End |
|---|---|---|
| SPEXIS AG | Director of Finance/CFO | - |
PricewaterhouseCoopers AG (Zurich)
 PricewaterhouseCoopers AG (Zurich) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers AG provides assurance, tax and advisory services. The company is headquartered in Zurich, Switzerland. | Comptroller/Controller/Auditor | - |
| ACINO HOLDING AG | Director of Finance/CFO | - |
Solvias AG
 Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BACHEM HOLDING AG | Health Technology |
| SPEXIS AG | Health Technology |
| Private companies | 3 |
|---|---|
Acino International AG
 Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
PricewaterhouseCoopers AG (Zurich)
PricewaterhouseCoopers AG (Zurich) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers AG provides assurance, tax and advisory services. The company is headquartered in Zurich, Switzerland. | Commercial Services |
Solvias AG
Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Alain Schaffter
